Sinovac Biotech, Ltd. · NASDAQ:SVA
Advantech Capital L.P. reported a 8.14% stake in Sinovac Biotech, Ltd. (Schedule 13D/A)
Event Jul 8, 2025 · Filed Jul 14, 2025
Advantech Capital L.P. reported a 8.14% stake in Sinovac Biotech, Ltd., 5,851,423 shares, with active intent on Jul 8, 2025. Filed Jul 14, 2025 (Schedule 13D/A).
- Stake
- 8.14%
- Shares
- 5,851,423
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Advantech Capital L.P. | 8.14% | 5,851,423 |
| Advantech Capital Partners Ltd. | 8.14% | 5,851,423 |
| Green Vision Partners Limited | 8.14% | 5,851,423 |
| Prime Success, L.P. | 8.14% | 5,851,423 |
Source
Related
- Sinovac Biotech, Ltd.
- Advantech Capital L.P.
- Sinovac Biotech, Ltd. shareholders
- Schedule 13D/A · Advantech Capital L.P. · Apr 10, 2025
- Schedule 13D · Advantech Capital L.P. · Mar 25, 2025
- Schedule 13D/A · SAIF Partners IV L.P. · Dec 17, 2025
- Schedule 13D/A · 1Globe Capital LLC · Sep 12, 2025
- Schedule 13D/A · Weidong Yin · Jul 15, 2025
- Schedule 13D/A · SAIF Partners IV L.P. · Jul 14, 2025
- Schedule 13D/A · Vivo Capital VIII, LLC · Jul 11, 2025